TINI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 5.759
EU - Europa 4.628
AS - Asia 2.973
SA - Sud America 583
Continente sconosciuto - Info sul continente non disponibili 254
AF - Africa 184
OC - Oceania 9
Totale 14.390
Nazione #
US - Stati Uniti d'America 5.569
RU - Federazione Russa 1.055
IT - Italia 990
CN - Cina 901
GB - Regno Unito 889
SG - Singapore 857
IE - Irlanda 507
BR - Brasile 465
VN - Vietnam 418
HK - Hong Kong 259
DE - Germania 247
SE - Svezia 226
UA - Ucraina 208
FR - Francia 190
KR - Corea 143
FI - Finlandia 116
ZA - Sudafrica 109
IN - India 102
CA - Canada 76
BD - Bangladesh 69
ES - Italia 63
AR - Argentina 41
TR - Turchia 40
MX - Messico 39
NL - Olanda 31
JP - Giappone 24
IQ - Iraq 22
PL - Polonia 19
BE - Belgio 18
CO - Colombia 17
ID - Indonesia 17
PK - Pakistan 17
AT - Austria 16
UZ - Uzbekistan 16
EC - Ecuador 15
NG - Nigeria 15
IR - Iran 13
LT - Lituania 13
KE - Kenya 12
MA - Marocco 12
TT - Trinidad e Tobago 12
JM - Giamaica 11
PY - Paraguay 11
SA - Arabia Saudita 11
CL - Cile 10
VE - Venezuela 10
AU - Australia 9
CR - Costa Rica 9
PR - Porto Rico 9
TN - Tunisia 9
ET - Etiopia 8
IM - Isola di Man 7
JO - Giordania 7
DZ - Algeria 6
GT - Guatemala 6
IL - Israele 6
MY - Malesia 6
NP - Nepal 6
PH - Filippine 6
TH - Thailandia 6
UY - Uruguay 6
HN - Honduras 5
NI - Nicaragua 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
EG - Egitto 4
GP - Guadalupe 4
PA - Panama 4
RO - Romania 4
AL - Albania 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
GA - Gabon 3
GR - Grecia 3
PE - Perù 3
SV - El Salvador 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
NO - Norvegia 2
OM - Oman 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GY - Guiana 1
Totale 14.126
Città #
Southend 725
Dallas 528
Dublin 495
Singapore 479
Ashburn 461
San Jose 401
Fairfield 371
Moscow 311
Santa Clara 308
Milan 257
Hong Kong 243
Chandler 239
Beijing 229
Hefei 214
Council Bluffs 201
Woodbridge 171
Wilmington 168
Ann Arbor 166
Jacksonville 166
Seattle 148
Houston 145
Seoul 142
New York 138
Ho Chi Minh City 136
Siena 131
Rome 122
Cambridge 107
Johannesburg 101
Menlo Park 98
Los Angeles 95
Hanoi 88
Princeton 72
The Dalles 70
Florence 69
Munich 64
Lauterbourg 55
Helsinki 53
Nanjing 52
Buffalo 48
Columbus 47
Dearborn 45
Fremont 43
Shanghai 36
Málaga 32
Boardman 30
Orem 30
London 28
São Paulo 28
Phoenix 26
Bengaluru 24
Izmir 24
Tianjin 24
Nuremberg 23
Tokyo 23
Dong Ket 22
Figino 22
North Bergen 22
San Diego 22
Chicago 21
Redondo Beach 21
Da Nang 20
Frankfurt am Main 20
San Mateo 20
Montreal 19
Turin 19
Naples 18
Toronto 18
Brooklyn 17
Brussels 17
Shenyang 17
Turku 17
Chennai 16
Guangzhou 16
Stockholm 16
Atlanta 15
Haiphong 15
Rio de Janeiro 15
Abuja 14
Mexico City 14
Palermo 14
Warsaw 14
Mumbai 13
Washington 13
Amsterdam 12
Brasília 12
Lappeenranta 12
Manchester 12
Nanchang 12
Tashkent 12
Bologna 11
Boston 11
Kunming 11
San Francisco 11
Vienna 11
Belo Horizonte 10
Florissant 10
Hebei 10
Jinan 10
Falkenstein 9
Poplar 9
Totale 9.222
Nome #
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 385
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 332
Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence 320
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 314
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 311
Diffusion-weighted magnetic resonance diagnosis of local recurrences of prostate cancer after radical prostatectomy: preliminary evaluation on twenty-seven cases 299
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 298
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 295
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 283
Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells 280
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 273
Beta-catenin and Gli1 are prognostic markers in glioblastoma 272
Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide 259
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and Temozolomide combined treatments 259
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 250
Autofagia nei gliomi HG: analisi ed interpretazione di dati clinici e biologici 243
Beta-Catenin and Gli-1 as prognostic markers in Glioblastoma Multiforme. 236
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status 232
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 227
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 226
Diffusion-weighted MR volumetry for assessing the response of rectal cancer to combined radiation therapy with chemotherapy 225
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 216
The prognostic role of Beclin 1 protein expression in high-grade gliomas 213
Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes 211
Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer) 206
Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective? 203
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 195
Challenges and Opportunities in Accessing Surgery for Glioblastoma in Low–Middle Income Countries: A Narrative Review 191
Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems 190
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 183
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 181
Feasibility of clinical target volume reduction for glioblastoma treated with standard chemoradiation based on patterns of failure analysis 180
Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism? 173
Epidermal Growth Factor Receptor Expression May Correlate with Survival Through Clinical and Radiological Features of Aggressiveness in Glioblastoma Treated with Radiochemotherapy 169
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 165
Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas 161
Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol 160
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 155
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 155
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 153
Correction to: Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery (Journal of Neuro-Oncology, (2024), 10.1007/s11060-024-04818-9) 150
In Regard to Kubicek et al. 149
Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery 140
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge 139
null 139
Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues 138
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 136
Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma 135
null 130
Comment on “Everolimus induces G1 cell cycle arrest through autophagy-mediated protein degradation of cyclin D1 in breast cancer cells” 126
null 126
Assessing ChatGPT-4 as a clinical decision support tool in neuro-oncology radiotherapy: a prospective comparative study 123
The role of delta radiomics in gastric cancer 120
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 120
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 119
The evolving role of reirradiation in the management of recurrent brain tumors 118
Persistent hiccup after chemo-radiotherapy in nasopharyngeal cancer: an atypical side effect? 117
null 117
null 116
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 116
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 114
Inflammatory markers and procalcitonin predict the outcome of metastatic non-small-cell-lung-cancer patients receiving PD-1/PD-L1 Immune-Checkpoint Blockade 114
Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer 112
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov 111
Tips and tricks of spinal cord biopsy: insights from a multicenter series of 61 patients 110
Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study 104
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 100
Delta-radiomics increases multicentre reproducibility: a phantom study 99
Letter to the Editor: Commentary on “Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma” 99
Watch the Mass, Save the Gland (Radiation Therapy Perhaps Later) 99
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 97
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 97
Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases 97
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 94
Stereotactic radiotherapy for brain oligometastases 92
Multimodality Imaging Assessment of Malignant Pleural Mesothelioma 92
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 89
Music therapy and radiation oncology: State of art and future directions 86
Role of the Appropriateness of the Pelvic Lymphadenectomy and Adjuvant Radiation Therapy in Early-Stage Poorly Differentiated Endometrial Carcinoma 84
null 83
null 82
How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies 82
Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas—prognostic significance in different biological sub-groups 71
Tumors of the optic nerve and its sheath 71
Cell Death Pathways, with Special Regard to Ionizing Radiation and Temozolomide 65
Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature? 61
Clinical, Pathological, and Molecular Prognostic Parameters in Glioblastoma Patients Undergoing Chemo- and Radiotherapy 60
miRNA Manipulation in Modifying Radiation Sensitivity in Glioblastoma Models 25
Mathematical Modelling of Radiobiological Parameters 24
Neurocognitive and neuropsychiatric presentation identifies a higher-risk clinical phenotype in IDH-wildtype glioblastoma: A retrospective cohort study 23
Totale 14.390
Categoria #
all - tutte 42.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022414 0 0 0 42 42 31 26 30 27 50 55 111
2022/2023847 46 73 126 109 78 149 23 68 75 43 26 31
2023/2024842 22 18 80 52 35 215 331 15 7 18 16 33
2024/20252.036 63 67 171 83 187 252 56 143 116 92 213 593
2025/20265.792 425 687 508 760 1.151 214 696 183 157 419 156 436
2026/20271.137 268 200 309 360 0 0 0 0 0 0 0 0
Totale 14.390